Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Nectar Lifesciences Ltd.

Nectar Lifesciences

NSE

0.00

0.00 (0.00)%

Healthcare

Small-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.

Subsidiaries

No Data Available

No Subsidiaries Data available

Management

2. Ajay Swaroop
Non Executive Independent Director

Contact Information

Company Address

Village Saidpura, Tehsil Dera Bassi,
Mohali Dist, Punjab - 147001
www.neclife.com
cs@neclife.com

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: einward.ris@karvy.comWebsite: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001
Phone: 040 - 67162222/18003094001
Email: einward.ris@kfintech.com
Website: www.kfintech.com

Company Profile

Nectar Lifesciences Ltd. (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. It has emerged as top ranked organization amongst midsized Pharmaceutical companies in India as per “Fortune Next 500” 2017 & is  among top 40 fore runners of the Bio-Pharmaceutical industry in Asia-Pacific Region as per “Bio-Spectrum Asia Pacific” 2016 besides being one of the top amongst Indian API manufacturers.

The company has transformed itself from being a small Domestic API player to one of the most integrated player in the Global Cephalosporins Industry within Anti Infective Therapeutic segment. It currently has a strong hold of API & Formulation business in many countries of the world with various State of Art manufacturing facilities spread across the States of Punjab and Himachal Pradesh with compliance to global standards of cGMP, Environment Health Safety (EHS) as well as pool of thousands of highly skilled, knowledgeable, competent qualified work force at all levels.

Business area of the company

The company has developed fully integrated sustainable production systems to manufacture high quality Cephalosporin intermediates, - Active Pharmaceuticals ingredients (APIs) and Finished Dosage Formulations (FDF or Formulations) to meet the diverse requirements of its customer base in India and over many countries worldwide.

Business segments

  • APIs
  • Formulations
  • Empty hard Gelatin Capsules
  • Phytochemicals

Certifications

  • GMP (Issued by World Health Organization - COPP)
  • ISO 9001:2008 - Quality Management
  • ISO 22000:2005 - Food Safety Management
  • ISO 14001: 2004 - Environment Management Systems
  • ISO 50001: 2011 - Energy Management System
  • OHSAS 18001: 2007 - Occupational Health and Safety
Enrich money logo